Michael Charles A. Booth
Nessuna posizione attualmente
Storia della carriera di Michael Charles A. Booth
Precedenti posizioni note di Michael Charles A. Booth
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| INCYTE CORPORATION | Contatto Relazioni con gli Investitori | 01/05/2014 | - |
| Corporate Officer/Principal | 01/05/2014 | 01/03/2021 | |
| Canaccord Adams Ltd. | Analyst-Equity | 20/06/2003 | 09/08/2007 |
| ALGETA ASA | Contatto Relazioni con gli Investitori | 17/10/2011 | - |
| Trout International LLC | Corporate Officer/Principal | 01/01/2007 | - |
Formazione di Michael Charles A. Booth
| University of Oxford | Doctorate Degree |
| University of St. Andrews | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Regno Unito | 5 |
| Stati Uniti | 2 |
| Norvegia | 2 |
Posizioni
| Investor Relations Contact | 2 |
| Corporate Officer/Principal | 2 |
| Analyst-Equity | 1 |
Settori
| Health Technology | 3 |
| Consumer Services | 3 |
| Finance | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| INCYTE CORPORATION | Health Technology |
| Aziende private | 3 |
|---|---|
| Canaccord Adams Ltd. | Finance |
| Trout International LLC | |
Algeta ASA
 Algeta ASA Pharmaceuticals: MajorHealth Technology Algeta ASA is engaged in the development of products for the treatment of cancer. The company focuses on the development of anti-cancer drugs, and its research and development of compounds focuses on the various applications of a few base compounds. Its products, Alpharadin and Thorium-227, are being developed for treatment of skeletal metastases originating from prostate and breast cancer. The company was founded by Roy H. Larsen and Øyvind Sverre Bruland in 1997 and is headquartered in Oslo, Norway. | Health Technology |
